ERG inhibition selectively sensitizes ERG-positive prostate cancer to radiation through DNA repair vulnerabilities and enhances response to androgen receptor inhibitors.
Overview & Synopsis
Open access biomedical research article published in J Exp Clin Cancer Res.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | ERG inhibition selectively sensitizes ERG-positive prostate cancer to radiation through DNA repair vulnerabilities and enhances response to androgen receptor inhibitors. |
|---|---|
| Author / Organization | Moustafa A, Elsesy ME, Siebels B, Hahn J, Oh-Hohenhorst SJ, Schudy C, Rieckmann T, Burdak-Rothkamm S, Tilki D, Maurer T, Petersen C, Rothkamm K, von Amsberg G, Bokemeyer C, Schlüter H, Köcher S, Mansour WY |
| Subject & Discipline | J Exp Clin Cancer Res |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-12508 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |